SCHEMBL29924718

SCHEMBL29924718

Fc1cc(C2CCCN2)ccc1C1=CN2c3ccccc3SC2N1CCCN1CCCCC1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 2/20 0.34
▸ PARP1 P09874 7/20 0.33
▸ PARP2 Q9UGN5 3/20 0.33
▸ MAP4K4 O95819 1/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ CLK2 P49760 1/20 0.31
▸ MAP4K2 Q12851 1/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ MINK1 Q8N4C8 1/20 0.31
▸ AURKB Q96GD4 1/20 0.31
▸ MAP4K5 Q9Y4K4 1/20 0.31
▸ F10 P00742 3/20 0.31
▸ KDM1A O60341 2/20 0.31
▸ LMNA P02545 1/20 0.30
▸ PGR P06401 1/20 0.30
▸ CHRM2 P08172 1/20 0.30
▸ HTR1A P08908 1/20 0.30
▸ ADRA2A P08913 1/20 0.30
▸ CHRM1 P11229 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29925414 1.00 FPR2 (0.34) FPR2PARP1PARP2MAP4K4CSF1R
SCHEMBL29925527 0.88 KDM1A (0.33) FPR2KDM1ALMNAPGRCHRM2
SCHEMBL29924650 0.82 FPR2 (0.36) FPR2KDM1ASLC6A4SLC6A3L3MBTL1
SCHEMBL29925004 0.77 KCNH2 (0.44) HTR1AADRA2ADRD1SLC6A2SLC6A4
SCHEMBL30085699 0.76 HRH3 (0.39) FPR2KDM1ALMNAKCNH2
SCHEMBL29924990 0.75 ADRA1D (0.33) FPR2KDM1A
SCHEMBL29925063 0.74 CD274 (0.37) FPR2KDM1ALMNACHRM2HTR1A
SCHEMBL29924842 0.73 CACNA1C (0.32) —
SCHEMBL30085724 0.73 HRH3 (0.36) FPR2KDM1AL3MBTL1
SCHEMBL30085708 0.73 HRH3 (0.37) FPR2KDM1ALMNACHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4274569-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER Anima Biotech Inc. (US) 2023-11-15 — — EP disclosed
WO-2022150316-A1 C-MYC MRNA TRANSLATION MODULATORS AND USES THEREOF IN THE TREATMENT OF CANCER ANIMA BIOTECH INC. (US) 2022-07-14 — — WO disclosed
Send feedback